ALBT
Avalon Globocare Corp
$
3.770
- Overview
- Forecast
- Valuation
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.770
Open
3.750
VWAP
3.74
Vol
11.17K
Mkt Cap
6.23M
Low
3.680
Amount
41.74K
EV/EBITDA(TTM)
--
Total Shares
11.10M
EV
34.73M
EV/OCF(TTM)
--
P/S(TTM)
2.05
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
Show More
Valuation Metrics
The current forward P/E ratio for Avalon Globocare Corp (ALBT.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Avalon Globocare Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2024Q4
YoY :
+7.61%
345.77K
Total Revenue
FY2024Q4
YoY :
+20.42%
-1.02M
Operating Profit
FY2024Q4
YoY :
-71.48%
-2.72M
Net Income after Tax
FY2024Q4
YoY :
-84.34%
-2.04
EPS - Diluted
FY2024Q4
-1.08M
Free Cash Flow
FY2024Q4
YoY :
-19.45%
21.50
Gross Profit Margin - %
FY2024Q4
YoY :
-28.30%
-372.67
FCF Margin - %
FY2024Q4
YoY :
-73.50%
-788.00
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ALBT News & Events
Events Timeline
2025-04-29 (ET)
2025-04-29
08:24:31
Avalon files registration statement for proposed YOOV merger
2025-04-15 (ET)
2025-04-15
08:11:19
Avalon partner with SpecialtyHealthto power Police Chiefs' fitness challenge
2025-04-10 (ET)
2025-04-10
08:13:22
Avalon announces issuance of patent for CAR-T, CAR-NK cell technology in China
Sign Up For More Events
Sign Up For More Events
News
7.0
05-03GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBT, NDOI, RDFN on Behalf of Shareholders
7.0
05-01Globenewswire$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ALBT, NDOI, DNB, RSLS
7.0
04-28PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWTX, RDUS, ALBT, BRDG on Behalf of Shareholders
Sign Up For More News
People Also Watch
MSFT
Microsoft Corp
452.940
USD
+0.85%
NVDA
NVIDIA Corp
135.340
USD
+4.16%
AMZN
Amazon.com Inc
210.250
USD
-0.53%
ORCL
Oracle Corp
162.950
USD
+0.42%
WMT
Walmart Inc
96.830
USD
+0.99%
TSLA
Tesla Inc
347.680
USD
+4.07%
AAPL
Apple Inc
212.330
USD
-0.28%
XOM
Exxon Mobil Corp
108.480
USD
-0.90%
AVGO
Broadcom Inc
232.120
USD
-0.13%
META
Meta Platforms Inc
659.360
USD
+0.51%
FAQ
What is Avalon Globocare Corp (ALBT) stock price today?
The current price of ALBT is 3.77 USD — it has decreased -0.53 % in the last trading day.
What is Avalon Globocare Corp (ALBT)'s business?
What is the price predicton of ALBT Stock?
What is Avalon Globocare Corp (ALBT)'s revenue for the last quarter?
What is Avalon Globocare Corp (ALBT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Avalon Globocare Corp (ALBT)'s fundamentals?
How many employees does Avalon Globocare Corp (ALBT). have?